Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.
Identifieur interne : 000517 ( Main/Exploration ); précédent : 000516; suivant : 000518Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.
Auteurs : Berthony Deslouches [États-Unis] ; Jonathan D. Steckbeck [États-Unis] ; Jodi K. Craigo [États-Unis] ; Yohei Doi [États-Unis] ; Jane L. Burns [États-Unis] ; Ronald C. Montelaro [États-Unis]Source :
- Antimicrobial agents and chemotherapy [ 1098-6596 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Anti-Bacterial Agents, Antimicrobial Cationic Peptides, Colistin, Rifampin.
- drug effects : Bacteria.
- Drug Resistance, Multiple, Bacterial, Microbial Sensitivity Tests.
Abstract
Multidrug resistance constitutes a threat to the medical achievements of the last 50 years. In this study, we demonstrated the abilities of two de novo engineered cationic antibiotic peptides (eCAPs), WLBU2 and WR12, to overcome resistance from 142 clinical isolates representing the most common multidrug-resistant (MDR) pathogens and to display a lower propensity to select for resistant bacteria in vitro compared to that with colistin and LL37. The results warrant an exploration of eCAPs for use in clinical settings.
DOI: 10.1128/AAC.03937-14
PubMed: 25421473
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000741
- to stream PubMed, to step Curation: 000741
- to stream PubMed, to step Checkpoint: 000741
- to stream Ncbi, to step Merge: 003F41
- to stream Ncbi, to step Curation: 003F41
- to stream Ncbi, to step Checkpoint: 003F41
- to stream Main, to step Merge: 000517
- to stream Main, to step Curation: 000517
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.</title>
<author><name sortKey="Deslouches, Berthony" sort="Deslouches, Berthony" uniqKey="Deslouches B" first="Berthony" last="Deslouches">Berthony Deslouches</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Steckbeck, Jonathan D" sort="Steckbeck, Jonathan D" uniqKey="Steckbeck J" first="Jonathan D" last="Steckbeck">Jonathan D. Steckbeck</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Craigo, Jodi K" sort="Craigo, Jodi K" uniqKey="Craigo J" first="Jodi K" last="Craigo">Jodi K. Craigo</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Doi, Yohei" sort="Doi, Yohei" uniqKey="Doi Y" first="Yohei" last="Doi">Yohei Doi</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Burns, Jane L" sort="Burns, Jane L" uniqKey="Burns J" first="Jane L" last="Burns">Jane L. Burns</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Pediatric Infectious Diseases, Seattle Children's Research Institute, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Seattle Children's Research Institute, Seattle, Washington</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Montelaro, Ronald C" sort="Montelaro, Ronald C" uniqKey="Montelaro R" first="Ronald C" last="Montelaro">Ronald C. Montelaro</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA rmont@pitt.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25421473</idno>
<idno type="pmid">25421473</idno>
<idno type="doi">10.1128/AAC.03937-14</idno>
<idno type="wicri:Area/PubMed/Corpus">000741</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000741</idno>
<idno type="wicri:Area/PubMed/Curation">000741</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000741</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000741</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000741</idno>
<idno type="wicri:Area/Ncbi/Merge">003F41</idno>
<idno type="wicri:Area/Ncbi/Curation">003F41</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003F41</idno>
<idno type="wicri:Area/Main/Merge">000517</idno>
<idno type="wicri:Area/Main/Curation">000517</idno>
<idno type="wicri:Area/Main/Exploration">000517</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.</title>
<author><name sortKey="Deslouches, Berthony" sort="Deslouches, Berthony" uniqKey="Deslouches B" first="Berthony" last="Deslouches">Berthony Deslouches</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Steckbeck, Jonathan D" sort="Steckbeck, Jonathan D" uniqKey="Steckbeck J" first="Jonathan D" last="Steckbeck">Jonathan D. Steckbeck</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Craigo, Jodi K" sort="Craigo, Jodi K" uniqKey="Craigo J" first="Jodi K" last="Craigo">Jodi K. Craigo</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Doi, Yohei" sort="Doi, Yohei" uniqKey="Doi Y" first="Yohei" last="Doi">Yohei Doi</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Burns, Jane L" sort="Burns, Jane L" uniqKey="Burns J" first="Jane L" last="Burns">Jane L. Burns</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Pediatric Infectious Diseases, Seattle Children's Research Institute, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Seattle Children's Research Institute, Seattle, Washington</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Montelaro, Ronald C" sort="Montelaro, Ronald C" uniqKey="Montelaro R" first="Ronald C" last="Montelaro">Ronald C. Montelaro</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA rmont@pitt.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Center for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Antimicrobial agents and chemotherapy</title>
<idno type="eISSN">1098-6596</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (pharmacology)</term>
<term>Antimicrobial Cationic Peptides (pharmacology)</term>
<term>Bacteria (drug effects)</term>
<term>Colistin (pharmacology)</term>
<term>Drug Resistance, Multiple, Bacterial</term>
<term>Microbial Sensitivity Tests</term>
<term>Rifampin (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (pharmacologie)</term>
<term>Bactéries ()</term>
<term>Colistine (pharmacologie)</term>
<term>Multirésistance bactérienne aux médicaments</term>
<term>Peptides antimicrobiens cationiques (pharmacologie)</term>
<term>Rifampicine (pharmacologie)</term>
<term>Tests de sensibilité microbienne</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Antimicrobial Cationic Peptides</term>
<term>Colistin</term>
<term>Rifampin</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Bacteria</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antibactériens</term>
<term>Colistine</term>
<term>Peptides antimicrobiens cationiques</term>
<term>Rifampicine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Resistance, Multiple, Bacterial</term>
<term>Microbial Sensitivity Tests</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Bactéries</term>
<term>Multirésistance bactérienne aux médicaments</term>
<term>Tests de sensibilité microbienne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multidrug resistance constitutes a threat to the medical achievements of the last 50 years. In this study, we demonstrated the abilities of two de novo engineered cationic antibiotic peptides (eCAPs), WLBU2 and WR12, to overcome resistance from 142 clinical isolates representing the most common multidrug-resistant (MDR) pathogens and to display a lower propensity to select for resistant bacteria in vitro compared to that with colistin and LL37. The results warrant an exploration of eCAPs for use in clinical settings.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Pennsylvanie</li>
<li>Washington (État)</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Deslouches, Berthony" sort="Deslouches, Berthony" uniqKey="Deslouches B" first="Berthony" last="Deslouches">Berthony Deslouches</name>
</region>
<name sortKey="Burns, Jane L" sort="Burns, Jane L" uniqKey="Burns J" first="Jane L" last="Burns">Jane L. Burns</name>
<name sortKey="Craigo, Jodi K" sort="Craigo, Jodi K" uniqKey="Craigo J" first="Jodi K" last="Craigo">Jodi K. Craigo</name>
<name sortKey="Doi, Yohei" sort="Doi, Yohei" uniqKey="Doi Y" first="Yohei" last="Doi">Yohei Doi</name>
<name sortKey="Montelaro, Ronald C" sort="Montelaro, Ronald C" uniqKey="Montelaro R" first="Ronald C" last="Montelaro">Ronald C. Montelaro</name>
<name sortKey="Steckbeck, Jonathan D" sort="Steckbeck, Jonathan D" uniqKey="Steckbeck J" first="Jonathan D" last="Steckbeck">Jonathan D. Steckbeck</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000517 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000517 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Amérique |area= PittsburghV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:25421473 |texte= Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25421473" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a PittsburghV1
This area was generated with Dilib version V0.6.38. |